Qifeng Sun

439 total citations
14 papers, 322 citations indexed

About

Qifeng Sun is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Qifeng Sun has authored 14 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Qifeng Sun's work include Electrocatalysts for Energy Conversion (3 papers), Fuel Cells and Related Materials (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Qifeng Sun is often cited by papers focused on Electrocatalysts for Energy Conversion (3 papers), Fuel Cells and Related Materials (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Qifeng Sun collaborates with scholars based in China. Qifeng Sun's co-authors include Xiaogang Zhao, Yanbin Shi, Guimei Lin, Yi Huang, Xianglei Fu, Shengnan Qiu, Chuanliang Peng, Lei Shan, Xiaopeng Dong and Junwen Luo and has published in prestigious journals such as Journal of Controlled Release, Small and Energy & Fuels.

In The Last Decade

Qifeng Sun

14 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qifeng Sun China 7 129 93 64 45 40 14 322
Tongfei Shi China 10 156 1.2× 119 1.3× 96 1.5× 20 0.4× 49 1.2× 12 513
Peirong Zhou China 10 116 0.9× 63 0.7× 60 0.9× 19 0.4× 17 0.4× 25 297
Sujing Qiang China 8 142 1.1× 162 1.7× 87 1.4× 23 0.5× 23 0.6× 12 461
Lihua Liang China 12 193 1.5× 68 0.7× 71 1.1× 46 1.0× 13 0.3× 24 432
Yuzhen Li China 12 123 1.0× 92 1.0× 44 0.7× 37 0.8× 9 0.2× 25 402
Yanan Zhou China 12 150 1.2× 77 0.8× 26 0.4× 41 0.9× 12 0.3× 33 405
Fatemeh Davodabadi Iran 9 123 1.0× 87 0.9× 79 1.2× 50 1.1× 22 0.6× 15 306
Nicola d’Avanzo Italy 14 217 1.7× 137 1.5× 181 2.8× 31 0.7× 102 2.5× 24 533

Countries citing papers authored by Qifeng Sun

Since Specialization
Citations

This map shows the geographic impact of Qifeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Sun more than expected).

Fields of papers citing papers by Qifeng Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Sun. The network helps show where Qifeng Sun may publish in the future.

Co-authorship network of co-authors of Qifeng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Sun. A scholar is included among the top collaborators of Qifeng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Sun. Qifeng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
3.
Sun, Qifeng, et al.. (2023). Relationship between pore structure of N-doped 3D porous graphene and electrocatalytic performance of oxygen reduction in zinc-air battery. Journal of Central South University. 30(5). 1490–1511. 5 indexed citations
4.
Fu, Xianglei, Yanbin Shi, Shengnan Qiu, et al.. (2020). Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Signal Transduction and Targeted Therapy. 5(1). 262–262. 103 indexed citations
5.
Shi, Yanbin, Yi Huang, Xianglei Fu, et al.. (2020). The role of antibody delivery formation in cancer therapy. Journal of drug targeting. 28(6). 574–584. 5 indexed citations
6.
Huang, Yi, Yanbin Shi, Qingjie Wang, et al.. (2019). Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. Journal of Controlled Release. 316. 208–222. 33 indexed citations
7.
Fu, Xianglei, Yanbin Shi, Hui Wang, et al.. (2019). <p>Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4</p>. International Journal of Nanomedicine. Volume 14. 9275–9284. 48 indexed citations
8.
Huang, Yi, Zili Gu, Qifeng Yang, et al.. (2019). Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future. Purinergic Signalling. 15(1). 53–67. 22 indexed citations
9.
Zhang, Weiquan, Junwen Luo, Xiaopeng Dong, et al.. (2019). Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients. Journal of Cancer. 10(7). 1651–1662. 75 indexed citations
10.
Zhao, Yunpeng, Ying‐Jie Chen, Xiaopeng Dong, et al.. (2019). Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method. Oncology Letters. 17(4). 3817–3825. 7 indexed citations
11.
Sun, Qifeng, et al.. (2016). Involvement of syk and VEGF-C in invasion of lung adenocarcinoma A549 cells. Journal of Cancer Research and Therapeutics. 12(2). 640–644. 4 indexed citations
12.
Zhao, Yunpeng, et al.. (2016). Development Pattern on Lymph Node Resection in Minimally Invasive Esophagectomy and 2-year Survival Analysis. The Thoracic and Cardiovascular Surgeon. 64(7). 606–610. 1 indexed citations
13.
Hou, Liang, Kang Chen, Yunpeng Zhao, et al.. (2015). Effect of Smac in combination with cisplatin on esophageal cancer cell line ECA109.. PubMed. 8(10). 18506–11. 1 indexed citations
14.
Peng, Chuanliang, et al.. (2014). Effect of Smac and Taxol on non-small-cell lung cancer. Acta Biochimica et Biophysica Sinica. 46(5). 387–393. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026